Changeflow GovPing Pharma & Drug Safety HSA Singapore New Drug Approvals - January 2026
Routine Notice Added Final

HSA Singapore New Drug Approvals - January 2026

Favicon for www.hsa.gov.sg HSA Singapore Announcements
Published January 1st, 2026
Detected March 23rd, 2026
Email

Summary

HSA Singapore announced new drug approvals for January 2026. This notice serves to inform stakeholders of the latest additions to the approved drug list.

View original document View source feed page

What changed

HSA Singapore has published a notice detailing new drug approvals for January 2026. This announcement lists the specific pharmaceutical products that have received regulatory clearance from the Health Sciences Authority.

Companies involved in the manufacturing and distribution of these drugs should note these additions for their product portfolios and ensure ongoing compliance with HSA regulations. This notice is informational and does not impose new compliance obligations beyond standard drug approval and post-market surveillance requirements.

Source document (simplified)

New Drug Approvals

Related changes

Favicon for www.hsa.gov.sg Keynote on Longevity Innovation, Regulation, and Collaboration
Routine Mar 23, 2026 • HSA Singapore Announcements • Pharma & Drug Safety
Favicon for www.hsa.gov.sg HSA Singapore: Adverse Effects from Banned Medicinal Products
Priority review Mar 23, 2026 • HSA Singapore Announcements • Pharma & Drug Safety
Favicon for www.hsa.gov.sg HSA Singapore SG-eCTD Version 1.1 Package Update
Routine Mar 23, 2026 • HSA Singapore Announcements • Pharma & Drug Safety
Favicon for www.ema.europa.eu EMA CHMP Meeting Agenda March 2026
Routine Mar 23, 2026 • EMA CHMP Agendas & Minutes • Pharma & Drug Safety
Favicon for www.ema.europa.eu EMA CHMP Meeting Agenda March 2026
Routine Mar 23, 2026 • EMA CHMP Agendas & Minutes • Pharma & Drug Safety
Favicon for changeflow.com EPO Patent Publication: Cathode Active Material for Lithium Secondary Battery
Routine Mar 23, 2026 • ChangeBridge: EPO Bulletin - Batteries (H01M) • Energy

Source

Favicon for www.hsa.gov.sg
HSA Singapore Announcements hsa.gov.sg/announcements
Pharma & Drug Safety
Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
HSA
Published
January 1st, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Approval
Geographic scope
Singapore SG

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Compliance frameworks
GxP
Topics
Drug Approval Regulatory Updates

Browse Categories

Agriculture & Food Safety 61 Banking & Finance 230 Consumer Protection 40 Courts & Legal 315 Data Privacy & Cybersecurity 63 Defense & National Security 48 Education 20 Energy 104 Environment 83 Government & Legislation 259 Healthcare 131 Housing 15 Immigration 9 Insurance 56 Labor & Employment 111 Legal & Courts 1 Pharma & Drug Safety 97 Securities & Markets 78 Tax 63 Telecom & Technology 47 Trade & Sanctions 124 Transportation 56

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when HSA Singapore Announcements publishes new changes.

Free. Unsubscribe anytime.